September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Fragile Maculas in Patients with Retinal Degeneration due to RPGR-ORF15 Mutations: Spatio-temporal Models of Disease Progression
Author Affiliations & Notes
  • Jason Charng
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Malgorzata Swider
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Rebecca Sheplock
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Alexander Sumaroka
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Alejandro J Roman
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Marc Christopher Peden
    Retina Associates of Florida, Tampa, Florida, United States
  • Elise Heon
    Ophthalmology and VisionSciences, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Sharon B Schwartz
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Samuel G Jacobson
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Artur V Cideciyan
    Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Jason Charng, None; Malgorzata Swider, None; Rebecca Sheplock, None; Alexander Sumaroka, None; Alejandro Roman, None; Marc Peden, None; Elise Heon, None; Sharon Schwartz, None; Samuel Jacobson, AGTC (P), AGTC (F); Artur Cideciyan, AGTC (P), AGTC (F)
  • Footnotes
    Support  AGTC, The Chatlos Foundation, Inc., FFB, RPB.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 156. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jason Charng, Malgorzata Swider, Rebecca Sheplock, Alexander Sumaroka, Alejandro J Roman, Marc Christopher Peden, Elise Heon, Sharon B Schwartz, Samuel G Jacobson, Artur V Cideciyan; Fragile Maculas in Patients with Retinal Degeneration due to RPGR-ORF15 Mutations: Spatio-temporal Models of Disease Progression. Invest. Ophthalmol. Vis. Sci. 2016;57(12):156.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : One of the most common molecular forms of retinitis pigmentosa (RP) is an X-linked (XL) disease caused by RPGR mutations in the ORF15 exon. Promising treatments include gene augmentation therapy demonstrating arrest of photoreceptor degeneration (Beltran et al. PNAS, 2012&2015). We measured macular photoreceptor structure and RPE disease in patients to evaluate retinal targets for eventual gene therapy trials.

Methods : We characterized RPGR-ORF15 patients (n=39, ages 10-51) with SD-OCT, autofluorescence, BCVA and foveal sensitivities.

Results : Refractions tended to be myopic (range -14D to +3D, median=-4D). 76% of patients had a BCVA of 20/32 or lower (range 20/20 to LP). Across the macula, there was a spectrum of disease severity and abnormalities were distributed across a range of spatial patterns. All eyes had abnormal macular structure by OCT. In 32 eyes, a detectable EZ layer extended only to 1.1° on average from the fovea along the horizontal and vertical meridians. Many eyes demonstrated a partial or complete parafoveal degeneration. In the perifovea, the majority of eyes showed no detectable EZ layer. In a few cases, EZ layer could be measured perifoveally, with a tendency of superior over inferior structural retention, which was also apparent on autofluorescence imaging. Foveal structure was an excellent predictor of foveal function. Macular imaging results were consistent with the hypothesis that RPGR-ORF15 disease showed a progressive spatio-temporal time course that could be described by the sum of central and peripheral components, each with a different natural history. Central disease would start parafoveally, encircle the fovea and annular fronts would expand centrifugally and centripetally. Peripheral disease would either start as a midperipheral annulus and expand centripetally towards the macula, or start in the inferior retina with a disease front sweeping across the macula from inferior to superior retina.

Conclusions : In most ORF15 patients, the EZ layer is either nondetectable or limited to the foveal region. Structural and functional measures suggest fragile maculas are not targets of experimental subretinal therapies. Future studies will evaluate extramacular regions in search of retained rods and cones that could be targeted with subretinal gene therapy.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×